CN Patent

CN101538245B — 一类哒嗪酮类化合物及其制备方法和制备药物的用途

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2011-02-16 · 15y expired

What this patent protects

本发明属于药物学领域，涉及一类哒嗪酮类化合物及其制备方法和用途，具体涉及以6-(3-(三氟甲基)苯基)哒嗪-3(2H)-酮为母核的具有下述结构式I所示的一类哒嗪酮类化合物及其制备方法和在制备抗肿瘤药物中的用途，尤其是这类化合物在抗肝癌药物中的用途。

USPTO Abstract

本发明属于药物学领域，涉及一类哒嗪酮类化合物及其制备方法和用途，具体涉及以6-(3-(三氟甲基)苯基)哒嗪-3(2H)-酮为母核的具有下述结构式I所示的一类哒嗪酮类化合物及其制备方法和在制备抗肿瘤药物中的用途，尤其是这类化合物在抗肝癌药物中的用途。

Drugs covered by this patent

tepotinib-hydrochloride (TEPOTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN101538245B
Jurisdiction: CN
Classification: —
Expires: 2011-02-16
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Institute of Materia Medica of CAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.